Furthermore, the results of Ki67 immunohistochemistry showed that when compound A was used in combination with chemotherapy drugs, the proliferation ability of tumor cells was further inhibited (Figure 13A,C) [48]. The gene discussed is MKI67; the disease is neoplasm.